1 active not recruiting, 1 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Completed 1 |
Follow Abraxane: new trials by email Literature Review of Abraxane trials Research Report on Abraxane
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma Atezolizumab, Nab paclitaxel, Carboplatin - Non-Small Cell Lung Cancer Metastatic | Phase 4 | Active not recruiting | Nikolaj Frost MD | 136 | 2023-12-06 | 2026-03-10 |
| Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly nab-paclitaxel, Carboplatin - Non-Small Cell Lung Cancer, Carcinoma | Phase 4 | Completed | Celgene | 143 | 2014-06-09 | 2018-09-24 |
Adenocarcinoma (1) · Carcinoma (1) · Carcinoma, Large Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1) · Lung Neoplasms (1)
Celgene (1) · Nikolaj Frost MD (1)
Germany (1) · United States (1)
Nikolaj Frost, PD Dr. (1) · Teng Jin Ong (1)